Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Umoja Biopharma
Biotech
Umoja secures $100M series C to bring more CAR-Ts into clinic
The release name-checked UB-VV400, an off-the-shelf, lentiviral vector designed to generate CD22-directed CAR-T cells within a patient’s body.
James Waldron
Jan 14, 2025 8:50am
Avenzo, Merck KGaA and AbbVie each ink new cancer deals
Jan 4, 2024 10:26am
Umoja's in vivo CAR-T therapy shows positive signs in primates
Sep 5, 2023 12:00pm
Umoja wants to move CAR T beyond the 'Goldilocks patients'
May 23, 2023 9:25am
Umoja aims immunotherapies at the clinic with $210M raise
Jun 15, 2021 7:00am
